We are live on ! Find out more
MIM

Marco Investment Management Portfolio holdings

AUM $1.52B
1-Year Est. Return 47.33%
This Fund
S&P 500
This Quarter Est. Return
+2.81%
1 Year Est. Return
+47.33%
3 Year Est. Return
+126.67%
5 Year Est. Return
+163.42%
10 Year Est. Return
+1,200.89%
AUM
$645M
AUM Growth
+$1.22M
Cap. Flow
-$13.1M
Cap. Flow %
-2.03%
Top 10 Hldgs %
29.83%
Holding
189
New
10
Increased
44
Reduced
91
Closed
6

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$3.32M
2
XOM icon
ExxonMobil
XOM
+$3.06M
3
GE icon
GE Aerospace
GE
+$2.95M
4
UNH icon
UnitedHealth
UNH
+$1.35M
5
PG icon
Procter & Gamble
PG
+$1.3M

Sector Composition

Rank Sector Weight
1 Healthcare 21.42%
2 Technology 20.29%
3 Financials 12.2%
4 Consumer Staples 8.42%
5 Industrials 7.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
26
AbbVie
ABBV
$431B
$7.85M 1.22%
84,697
+433
+0.5% +$42.3K
ABT icon
27
Abbott
ABT
$187B
$7.64M 1.18%
125,305
-297
-0.2% -$18K
KMB icon
28
Kimberly-Clark
KMB
$36.1B
$6.79M 1.05%
64,477
+1,650
+3% +$171K
MOS icon
29
The Mosaic Company
MOS
$7.46B
$6.66M 1.03%
237,308
-1,499
-0.6% -$40.7K
UNP icon
30
Union Pacific
UNP
$175B
$6.64M 1.03%
46,852
-5,535
-11% -$772K
APA icon
31
APA Corp
APA
$12.9B
$6.55M 1.02%
140,175
-2,450
-2% -$102K
AXP icon
32
American Express
AXP
$231B
$6.46M 1%
65,934
-2,397
-4% -$236K
HUN icon
33
Huntsman Corp
HUN
$1.78B
$6.42M 1%
220,000
ALB icon
34
Albemarle
ALB
$14.8B
$6.23M 0.97%
66,000
+5,200
+9% +$499K
ESRX
35
DELISTED
Express Scripts Holding Company
ESRX
$6.12M 0.95%
79,246
+49,696
+168% +$3.73M
ORCL icon
36
Oracle
ORCL
$413B
$5.83M 0.9%
132,428
-1,500
-1% -$69.1K
PG icon
37
Procter & Gamble
PG
$342B
$5.49M 0.85%
70,339
-17,252
-20% -$1.3M
NXPI icon
38
NXP Semiconductors
NXPI
$58.4B
$5.48M 0.85%
50,150
-1,300
-3% -$143K
LLL
39
DELISTED
L3 Technologies, Inc.
LLL
$5.46M 0.85%
28,400
+1,005
+4% +$201K
DUK icon
40
Duke Energy
DUK
$96.6B
$5.41M 0.84%
68,434
-568
-0.8% -$43.7K
COP icon
41
ConocoPhillips
COP
$142B
$5.4M 0.84%
77,502
+1,398
+2% +$93.1K
AFL icon
42
Aflac
AFL
$64.5B
$5.33M 0.83%
123,848
-11,600
-9% -$521K
PFE icon
43
Pfizer
PFE
$149B
$5.3M 0.82%
153,993
-8,241
-5% -$282K
WMT icon
44
Walmart Inc
WMT
$892B
$5.18M 0.8%
181,557
-1,482
-0.8% -$42.1K
DIS icon
45
Walt Disney
DIS
$182B
$5.11M 0.79%
48,777
+1,615
+3% +$165K
GOOGL icon
46
Alphabet (Google) Class A
GOOGL
$4.38T
$4.83M 0.75%
85,520
+7,760
+10% +$422K
PYPL icon
47
PayPal
PYPL
$51.1B
$4.81M 0.75%
57,779
-584
-1% -$46.5K
SCHW
48
Charles Schwab
SCHW
$187B
$4.4M 0.68%
86,124
-2,200
-2% -$122K
MU icon
49
Micron Technology
MU
$996B
$4.22M 0.65%
80,565
+4,250
+6% +$230K
MRK icon
50
Merck
MRK
$317B
$4.15M 0.64%
71,710
-19,231
-21% -$1.08M

Similar funds

Marco Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, Marco Investment Management held 189 positions worth $645M, up 0.19% from $644M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Marco Investment Management's Q2 2018 filing shows 10 new, 44 increased, 91 reduced and 6 closed positions. Its largest new stake was Schwab International Equity ETF: 84,996 shares worth $1.41M. The largest sale was Medtronic, an estimated $3.32M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

  • Marco Investment Management's largest Q2 2018 buy was Schwab International Equity ETF: 84,996 shares worth $1.41M.
  • Marco Investment Management added most to Goldman Sachs in Q2 2018, an estimated $4.05M increase.
  • Marco Investment Management's biggest Q2 2018 reduction was Medtronic, cutting an estimated $3.32M.
  • Marco Investment Management fully exited Monsanto Co in Q2 2018, selling an estimated $947K.
  • Marco Investment Management's ten largest holdings make up 30% of its $645M portfolio in Q2 2018.
  • Marco Investment Management opened 10 new positions and closed 6 in Q2 2018.
  • Marco Investment Management's portfolio value rose 0.19% quarter-over-quarter to $645M.

Based on Marco Investment Management's 13F filing for Q2 2018, filed 10 Aug 2018.